300 related articles for article (PubMed ID: 12598709)
1. Seborrheic Keratosis-like lesions in patients with epidermodysplasia verruciformis.
Roncalli de Oliveira W; Neto CF; Rady PL; Tyring SK
J Dermatol; 2003 Jan; 30(1):48-53. PubMed ID: 12598709
[TBL] [Abstract][Full Text] [Related]
2. Detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in nongenital seborrhoeic keratosis.
Li YH; Chen G; Dong XP; Chen HD
Br J Dermatol; 2004 Nov; 151(5):1060-5. PubMed ID: 15541085
[TBL] [Abstract][Full Text] [Related]
3. Seborrheic keratosis-like lesions in epidermodysplasia verruciformis.
Tomasini C; Aloi F; Pippione M
J Cutan Pathol; 1993 Jun; 20(3):237-41. PubMed ID: 8396161
[TBL] [Abstract][Full Text] [Related]
4. Incidental epidermodysplasia verruciformis human papillomavirus infection (EV acanthoma): evidence for 'field cancerization' and a putative cofactor in seborrheic keratosis.
Rohwedder A; Foong H; Tyring SK; Rady P; Carlson JA
J Cutan Pathol; 2008 Dec; 35(12):1151-5. PubMed ID: 18494819
[No Abstract] [Full Text] [Related]
5. Changes of epidermodysplasia verruciformis in benign skin lesions: the EV acanthoma.
Ko CJ; Iftner T; Barr RJ; Binder SW
J Cutan Pathol; 2007 Jan; 34(1):44-8. PubMed ID: 17214854
[TBL] [Abstract][Full Text] [Related]
6. A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome.
Kreuter A; Hochdorfer B; Brockmeyer NH; Altmeyer P; Pfister H; Wieland U;
Arch Dermatol; 2008 Mar; 144(3):366-72. PubMed ID: 18347293
[TBL] [Abstract][Full Text] [Related]
7. Seborrheic keratoses of black patients with epidermodysplasia verruciformis contain human papillomavirus DNA.
Jacyk WK; Dreyer L; de Villiers EM
Am J Dermatopathol; 1993 Feb; 15(1):1-6. PubMed ID: 8382012
[TBL] [Abstract][Full Text] [Related]
8. Four familial cases of epidermodysplasia verruciformis: mother and three sons.
Robati RM; Marefat A; Saeedi M; Rahmati-Roodsari M; Asadi-Kani Z
Dermatol Online J; 2009 Apr; 15(4):8. PubMed ID: 19450401
[TBL] [Abstract][Full Text] [Related]
9. Epidermodysplasia verruciform-like Lesions in an HIV patient.
Berk DR; Bruckner AL; Lu D
Dermatol Online J; 2009 Jan; 15(1):1. PubMed ID: 19281706
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.
Harwood CA; Surentheran T; Sasieni P; Proby CM; Bordea C; Leigh IM; Wojnarowska F; Breuer J; McGregor JM
Br J Dermatol; 2004 May; 150(5):949-57. PubMed ID: 15149508
[TBL] [Abstract][Full Text] [Related]
11. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
[TBL] [Abstract][Full Text] [Related]
12. A novel human papillomavirus identified in epidermodysplasia verruciformis.
Harris AJ; Purdie K; Leigh IM; Proby C; Burge S
Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964
[TBL] [Abstract][Full Text] [Related]
13. Epidermodysplasia-verruciformis-like eruption associated with gamma-papillomavirus infection in a patient with adult T-cell leukemia.
Kawai K; Egawa N; Kiyono T; Kanekura T
Dermatology; 2009; 219(3):274-8. PubMed ID: 19696474
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic aspects of epidermodysplasia verruciformis (L-L 1922) in Japan.
Tanigaki T; Kanda R; Yutsudo M; Hakura A
Jpn J Cancer Res; 1986 Sep; 77(9):896-900. PubMed ID: 3095286
[TBL] [Abstract][Full Text] [Related]
15. Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion.
Majewski S; Jablonska S
Cancer Res; 1997 Oct; 57(19):4214-6. PubMed ID: 9331078
[TBL] [Abstract][Full Text] [Related]
16. Development of aggressive squamous cell carcinoma in epidermodysplasia verruciformis associated with human papillomavirus type 22b.
Kim T; Park JC; Roh MR; Park JM; Kim SH; Cho NH; Lee MG
Dermatology; 2010; 220(4):326-8. PubMed ID: 20460877
[TBL] [Abstract][Full Text] [Related]
17. Acquired epidermodysplasia verruciformis.
Rogers HD; Macgregor JL; Nord KM; Tyring S; Rady P; Engler DE; Grossman ME
J Am Acad Dermatol; 2009 Feb; 60(2):315-20. PubMed ID: 19150275
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of epidermodysplasia verruciformis.
Hoffner MV; Camacho FM
Dermatol Surg; 2010 Mar; 36(3):363-7. PubMed ID: 20100263
[TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of epidermodysplasia verruciformis and review of the literature.
Gül U; Kiliç A; Gönül M; Cakmak SK; Bayis SS
Int J Dermatol; 2007 Oct; 46(10):1069-72. PubMed ID: 17910717
[TBL] [Abstract][Full Text] [Related]
20. [Polyclonal antibody to human papillomavirus-related antigens specific to epidermodysplasia verruciformis].
Ishiji T
Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):683-95. PubMed ID: 2479785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
